Integrated Continuous Biomanufacturing
Integrated Continuous Biomanufacturing is a biopharmaceutical production framework that integrates multiple unit operations into a single, uninterrupted process to enable end-to-end continuous manufacturing of biologics, distinguishing itself from batch or partially continuous methods by its seamless connectivity and real-time control across upstream and downstream stages.
32
Publications
2.1K
Citations
141
Authors
54
Institutions
Publications per year
2017–2026
26
Variants
End-to-end Continuous Biomanufacturing
Parents
32
Integrated continuous production of recombinant therapeutic proteins
Veena Warikoo, Rahul Godawat, Kevin Brower et al. · Biotechnology and Bioengineering · 2012 · 419 citations
1–5 of 32
141
4
h-index
4
h-index
3
h-index
3
h-index
3
h-index
1–5 of 141
54
BOKU University
Vienna, Austria
4 h-index
10 publications
281 citations
Austrian Centre of Industrial Biotechnology (Austria)
Graz, Austria
4 h-index
12 publications
357 citations

Lund University
Lund, Sweden
3 h-index
9 publications
347 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
3 h-index
2 publications
63 citations
Sanofi (United States)
Bridgewater, United States
2 h-index
10 publications
570 citations
Pfizer (United States)
New York, United States
2 h-index
3 publications
423 citations
Bioprocess Control (Sweden)
Lund, Sweden
2 h-index
4 publications
177 citations
AstraZeneca (Japan)
Osaka, Japan
1 h-index
2 publications
46 citations
1–8 of 54
10 publications · 925 citations
10
h-index
3 publications · 268 citations
3
h-index
2 publications · 107 citations
2
h-index
2 publications · 92 citations
2
h-index
1 publications · 13 citations
2
h-index
1–5